A Trial to Determine the Safety and Tolerability of Transplanted Stem Cell Derived Dopamine Neurons to the Brains of Individuals With Parkinson's Disease
Clinical trial NCT05635409 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05635409
- Sponsor
- Region Skane
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-30
- Primary completion
- 2027-01-01
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.